
Xelomic ET 250mg/250mg Tablet
Marketer
Mediyork Pharma Pvt Ltd
Salt Composition
Tranexamic Acid (250mg) + Ethamsylate (250mg)
Overview Xelomic ET 250mg/250mg Tablet
Tranexamic acid and ethinylestradiol 250mg/250mg tablets are prescribed for managing heavy menstrual bleeding. This medication's dual action inhibits clot breakdown, thus reducing excessive blood flow, and enhances platelet aggregation for improved clotting. The tablets can be ingested at any time, with or without food, but consistent daily timing is recommended. Continue the treatment for the prescribed duration. Take the medicine as directed; if a dose is missed, take it immediately upon recollection. Complete the entire course of treatment, even if symptoms improve. Abrupt cessation should only occur after consulting your physician. Common side effects include nausea, abdominal discomfort, headache, nasal stuffiness, sinusitis, skin rash, fatigue, and musculoskeletal pain. Diarrhea is also possible; increased fluid intake is advised to mitigate dehydration. If no menstrual flow improvement is observed after three consecutive cycles, consult your doctor. Prior to starting this medication, inform your doctor of any kidney issues, vaginal bleeding disorders, pregnancy, breastfeeding, or other medications you are currently taking. Regular eye examinations may be necessary during treatment.
Uses of Xelomic ET 250mg/250mg Tablet
Profound menstrual hemorrhage
Major Benefits of Xelomic ET 250mg/250mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and schedule. Ingest the 250mg/250mg Xelomic ET Tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable; however, consistent timing is recommended.
Common Side effects of Xelomic ET 250mg/250mg Tablet:
- Nausea
- Stomach pain
- Diarrhea
- Headache
- Nasal congestion (stuffy nose)
- Sinus pain
- Sinus inflammation
- Rash
- Tiredness
- Musculoskeletal (bone, muscle or joint) pain
- Anemia (low number of red blood cells)
How to use Xelomic ET 250mg/250mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the 250mg/250mg Xelomic ET Tablet whole; avoid chewing, crushing, or fracturing. Consumption may coincide with meals or be taken independently, though consistent timing is recommended.
How Xelomic ET 250mg/250mg Tablet works:
Xelomic ET 250mg/250mg tablets contain Tranexamic Acid and Ethamsylate, two drugs that work synergistically to manage bleeding. Tranexamic acid, an antifibrinolytic agent, stabilizes blood clots by inhibiting their breakdown. Ethamsylate, a hemostatic, enhances platelet aggregation, promoting clot formation and stemming bleeding, particularly from small capillaries.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Xelomic ET 250mg/250mg tablets and alcohol may result in increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Data on Xelomic ET 250mg/250mg Tablet use in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Xelomic ET 250mg/250mg tablets while breastfeeding is lacking. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Xelomic ET 250mg/250mg Tablets.
KidneyCAUTION
Patients with kidney impairment should use Xelomic ET 250mg/250mg Tablets cautiously; dosage modifications may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Xelomic ET 250mg/250mg tablets in patients with liver impairment is likely safe. Preliminary findings indicate dose modification may be unnecessary; however, medical advice is recommended.
What if you forget to take Xelomic ET 250mg/250mg Tablet :
Should you forget a dose of Xelomic ET 250mg/250mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Xelomic ET 250mg/250mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | KINSHIP |
